Holen Sie sich die Stockscreener-App
8.35
1.76%
-0.15
Schlusskurs vom Vortag:
$8.50
Offen:
$8.58
24-Stunden-Volumen:
670.25K
Relative Volume:
1.08
Marktkapitalisierung:
$428.66M
Einnahmen:
$57.94M
Nettoeinkommen (Verlust:
$-151.18M
KGV:
-2.9698
EPS:
-2.8116
Netto-Cashflow:
$-86.56M
1W Leistung:
-5.54%
1M Leistung:
+1.33%
6M Leistung:
-20.63%
1J Leistung:
-17.24%
1-Tages-Spanne:
$8.24
$8.62
1-Wochen-Bereich:
$8.19
$8.81
52-Wochen-Spanne:
$7.73
$11.80
Prothena Corp Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corp Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTA
Prothena Corp Plc
|
8.35 | 428.66M | 57.94M | -151.18M | -86.56M | -2.8116 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Prothena Corp Plc Stock (PRTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-27 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-04-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-05-26 | Eingeleitet | Citigroup | Buy |
| 2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
| 2018-04-05 | Bestätigt | Barclays | Overweight |
| 2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2017-09-29 | Bestätigt | BTIG Research | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-12-21 | Eingeleitet | SunTrust | Buy |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2016-08-04 | Bestätigt | Barclays | Overweight |
| 2016-05-13 | Eingeleitet | Barclays | Overweight |
| 2016-02-19 | Bestätigt | Wedbush | Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corp Plc Aktie (PRTA) Neueste Nachrichten
Form 4 PROTHENA CORP PUBLIC LTD CO For: 11 October By Investing.com - Investing.com Nigeria
Form 4 PROTHENA CORP PUBLIC LTD CO For: 10 October By Investing.com - Investing.com Canada
Form 4 PROTHENA CORP PUBLIC LTD CO For: 10 October By Investing.com - Investing.com India
Form 4 PROTHENA CORP PUBLIC LTD CO For: 10 October By Investing.com - Investing.com South Africa
CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
Prothena Director William P. Scully Acquires 100,000 Shares at $8.57 Each - Kalkine Media
Insider Stock Purchases: October 06, 2026 - Quiver Quantitative
A development chief is leaving Prothena (PRTA) to join one of its strategic partners. - stocktitan.net
Prothena Corporation Public Limited Company Announces Resignation of Chad J. Swanson, Ph.D. as Chief Development Officer, Effective October 9, 2026 - marketscreener.com
Form 4 PROTHENA CORP PUBLIC LTD CO For: 1 October By Investing.com - Investing.com Canada
Form 4 PROTHENA CORP PUBLIC LTD CO For: 29 September By Investing.com - Investing.com Nigeria
Form 4 PROTHENA CORP PUBLIC LTD CO For: 29 September By Investing.com - Investing.com Canada
Form 4 PROTHENA CORP PUBLIC LTD CO For: 29 September By Investing.com - Investing.com UK
Form 4 PROTHENA CORP PUBLIC LTD CO For: 27 September - Investing.com India
Insider Stock Purchases: September 24, 2026 - Quiver Quantitative
Prothena Director William P. Scully Acquires 100,000 Shares at Average Price of $8.43 - kalkinemedia.com
Prothena Corp Public Ltd Insider Bought Shares Worth $843,460, According to a Recent SEC Filing - Yahoo Finance
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
A biotech company's leaders will speak live in New York Sept. 16 - Stock Titan
Prothena stock holds near USD 9.60 after market cap update - AD HOC NEWS
Prothena Director William P. Scully Acquires 27,000 Shares in Open Market - kalkinemedia.com
Responsive Playbooks and the PRTA Inflection - Stock Traders Daily
Sarissa Capital Management and Alexander J. Denner Hold 25.7 Million Shares in Amarin Corporation (NASDAQ: AMRN) - kalkinemedia.com
Prothena Corporation plc (PRTA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Prothena Stock Price Forecast. Should You Buy PRTA? - StockInvest.us
Prothena Corporation plc (PRTA) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Prothena Corporation plc (PRTA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Prothena (NASDAQ:PRTA) Major Shareholder Buys 50,000 Shares of Stock - MarketBeat
Prothena (NASDAQ: PRTA) insider lifts direct stake to 800,000 shares - stocktitan.net
Trustee controls a tenth of Prothena (PRTA) stock via trusts - Stock Titan
Prothena (NASDAQ:PRTA) Shares Pass Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Prothena (PRTA) Holds Steady Near $8.88 as Shares Sit Between Key Support and ResistancePositive Gamma - vinanet.vn
Prothena (PRTA) 10% holder logs 963K-share gifts - Stock Titan
Precision Trading with Prothena Corporation Plc (PRTA) Risk Zones - Stock Traders Daily
HC Wainwright Issues Positive Estimate for Prothena Earnings - MarketBeat
Prothena (PRTA) Stock Shrugs Off Revenue Drop As Pipeline Stakes Rise - Sahm
Prothena Corporation PLC (PRTA) Stock News Today - TradingKey
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - tradingview.com
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - Yahoo Finance
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - BioSpace
Prothena (NASDAQ:PRTA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Prothena Corporation PLC reports results for the quarter ended June 30Earnings Summary - tradingview.com
Prothena: Q2 Earnings Snapshot - marketscreener.com
Prothena: Q2 Earnings Snapshot - Yahoo Finance
Prothena (NASDAQ: PRTA) turns H1 2026 profit on $50M milestone - Stock Titan
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - marketscreener.com
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - Yahoo Finance
FMR LLC discloses 13.8% Prothena (PRTA) ownership; key fund holds 6.4% - stocktitan.net
Renaissance Technologies LLC Has $5.91 Million Stock Position in Prothena Corporation plc $PRTA - MarketBeat
Finanzdaten der Prothena Corp Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prothena Corp Plc-Aktie (PRTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SCULLY WILLIAM P | 10% Owner |
Oct 14 '26 |
Buy |
8.46 |
10,000 |
84,569 |
1,037,000 |
| SCULLY WILLIAM P | 10% Owner |
Oct 08 '26 |
Buy |
8.57 |
90,000 |
770,904 |
529,000 |
| SCULLY WILLIAM P | 10% Owner |
Oct 07 '26 |
Buy |
8.40 |
125,000 |
1,050,150 |
439,000 |
| SCULLY WILLIAM P | 10% Owner |
Oct 02 '26 |
Buy |
8.57 |
100,000 |
857,240 |
314,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 29 '26 |
Buy |
8.68 |
162,000 |
1,405,674 |
214,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 28 '26 |
Buy |
8.60 |
103,500 |
889,872 |
187,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 18 '26 |
Buy |
8.43 |
100,000 |
843,460 |
927,000 |
| SCULLY WILLIAM P | 10% Owner |
Sep 02 '26 |
Buy |
9.47 |
27,000 |
255,739 |
827,000 |
| SCULLY WILLIAM P | 10% Owner |
Aug 20 '26 |
Buy |
8.79 |
50,000 |
439,430 |
800,000 |
| SCULLY WILLIAM P | 10% Owner |
Aug 07 '26 |
Buy |
8.62 |
3,500 |
30,167 |
83,500 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):